50 of the Top 250 law firms use our Products every day
Exhibit 4.4
CLINICAL RESEARCH CONSULTING AGREEMENT
(renewed)
THIS CLITICAL RESEARCH
AGREEMENT is made
effective this 1 st day of 2005 by and;
BETWEEN:
WOO-KYUNG SEO, 403-909, 4th
Block, Tanhyun Village, Tanhyun-Dong, Ilsan-Ku, Koyang-City,
Kyeonggi-Do, Korea (hereinafter referred to as
“CONSULTANT”)
AND:
MERIDIAN CO., LTD., of 9Fl.,
Seoil Bldg. 222, Jamsilbon-dong, Songpa-gu Seoul, Republic of Korea
(hereinafter referred to as “MERIDIAN”)
WHEREAS:
A.
MERIDIAN is engaged in the research, development, manufacturing and
sales of medical devices mainly for the Oriental and
Natural/Alternative Medicine;
B.
CONSULTANT is a medical professional providing clinical research
services in the North American regulatory standard; and
C.
MERIDIAN considers it to be in its best interest to engage
CONSULTANT to receive clinical research consulting services for its
products in North America on the terms and subject to the
conditions hereinafter set forth.
NOW THEREFORE THIS AGREEMENT
WITNESS THAT the parties mutually agree as follows:
A.
ENGAGEMENT
|
1.3
|
Subject to the
terms and conditions hereof, MERIDIAN hereby engages CONSULTANT to
receive the clinical research services set out in Section 2 hereof
(the “Services”).
|
|
|
|
1.4
|
CONSULTANT’s obligation to perform the
Services shall commence following the completion of the list of the
Services, and will continue from the Effective Date until
terminated in accordance with Article 4 hereof (the
“Term”).
|
B.
SERVICES
|
2.1
|
Conduct the
medical research on every products of MERIDIAN, which is acceptable
in the US medical industry.
|
|
|
|
2.2
|
Prepare the
appropriate research results for the Meridian Products to meet the
FDA standard.
|
|
|
|
2.3
|
Examine the
products for FDA regulations (510(k)), Pre-market Approval,
Investigation Device Exemption.
|
C.
CONSIDERATION
|
